ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Influencia de factores de riesgo sobre mortalidad por COVID-19 / Influence of risk factors on mortality from COVID-19

Jorge Ayón-Aguilar, Socorro Méndez-Martínez, Ricardo Toledo-Tapia, Máximo Alejandro García-Flores, Antonio Mayoral-Ortiz, Nataly Tlecuitl-Mendoza, Mariana Toledo-Tapia, Melissa Ortega-Aguirre, Eileen Amaro-Balderas

Resumen


Resumen

Introducción:  los principales factores de riesgo estudiados que tienen influencia sobre la mortalidad por COVID-19 han sido hasta el momento inconclusos en la literatura mundial, principalmente en relación al sexo masculino.

Objetivo: determinar cuáles son los principales factores de riesgo que influyen sobre una mayor mortalidad por COVID-19.

Material y métodos: se realizó un estudio de casos y controles, incluyendo a 1190 pacientes con PCR-RT positiva. Los factores de riesgo estudiados fueron: sexo, edad, presencia de hipertensión arterial sistémica (HAS), diabetes mellitus (DM), obesidad, enfermedad pulmonar obstructiva crónica (EPOC), asma, tabaquismo, pacientes con ingesta de inmunosupresores, portadores del virus de inmunodeficiencia humana (VIH) y vacuna de influenza. En el grupo de casos fallecieron por COVID-19 (n = 576), mientras que en el de controles sobrevivieron (n = 614). El plan estadístico incluyó tablas cruzadas y modelo de regresión logística multivariable para determinar la influencia de estos factores de riesgo sobre la mortalidad por COVID-19.

Resultados: no encontramos diferencias estadísticamente significativas entre casos y controles en relación al sexo. Sin embargo, los casos presentaron: edad > 60 años, HAS, DM y obesidad, en comparación con los controles.

Conclusiones: el sexo masculino no fue factor de riesgo para mortalidad por COVID-19, sin embargo, otros factores de riesgo como edad mayor de 60 años, ser hipertenso, diabético y obeso, sí se corroboraron como tales para una mayor mortalidad por COVID-19.

 

Abstract

Background: The main risk factors studied that have an influence on mortality from COVID-19 have so far been inconclusive in the world literature, mainly in relation to the male gender.

Objective: To determine which are the main risk factors that influence a higher mortality from COVID-19.

Material and methods: A case-control study was conducted, including 1190 patients with positive RT-PCR. The risk factors studied were: gender, age, systemic arterial hypertension (SAH), Diabetes mellitus (DM), obesity, Chronic Obstructive Pulmonary Disease (COPD), asthma, smoking, immunosuppressants, Human Immunodeficiency Virus (HIV), influenza vaccine. In the Group of Cases: they died from COVID-19 (n = 576), while in the Controls group: they survived (n = 614). The statistical plan included cross-tables and multivariate logistic regression model to determine the influence of these risk factors on mortality from COVID-19.

Results: We found no statistically significant differences between cases and controls in relation to gender. However, the cases were aged >60 years, SAH, DM, obesity compared to controls.

Conclusions: Male gender was not a risk factor for mortality from COVID-19, however, other risk factors such as age over 60 years, being hypertensive, diabetic and obese, were corroborated as such for a higher mortality from COVID-19.

 

 


Palabras clave


Factores de Riesgo; Mortalidad; Infecciones por Coronavirus; COVID-19 / Risk Factors; Mortality Coronavirus Infections COVID-19

Texto completo:

PDF

Referencias


Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(6):767-772. DOI: 10.1016/j.cmi.2020.04.012.

 

Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract. 2020;166:108293. DOI: 10.1016/j.diabres.2020.108293.

 

Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief review of the risk factors for covid-19 severity. Rev Saude Publica. 2020;54:60. DOI: 10.11606/s1518-8787.2020054002481.

 

Fisman DN, Bogoch I, Lapointe-Shaw L, McCready J, Tuite AR. Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada. JAMA Network Open. 2020;3(7):e2015957. DOI: 10.1001/ jamanetworkopen.2020.15957.

 

Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198. DOI: 10.1136/bmj.m1198.

 

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-118. DOI: 10.1016/j. jaci.2020.04.006.

 

Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020; 55(5):2000547. DOI: 10.1183/13993003.00547-2020.

 

Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. The Lancet. 2020;395(10229):1014-1015. DOI: 10.1016/S0140-6736(20)30633-4.

 

Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit Care. 2020; 24(1):108. DOI: 10.1186/s13054-020-2833-7.

 

Rozenfeld Y, Beam J, Maier H, Haggerson W, Boudreau K, Carlson J, et al. A model of disparities: risk factors associated with COVID-19 infection. Int J Equity Health. 2020;19(1):126. DOI: 10.1186/s12939-020-01242-z.

 

Sousa GJB, Garces TS, Cestari VRF, Florêncio RS, Moreira TMM, Pereira MLD. Mortality and survival of COVID-19. Epidemiol Infect. 2020;148:e123. DOI: 10.1017/S0950268820001405.

 

Martins-Filho PR, Tavares CSS, Santana-Santos V. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020;76:97-99. DOI: 10.1016/j.ejim.2020.04.043.

 

Rogado J, Obispo B, Pangua C, Serrano-Montero G, Martín-Marino A, Pérez-Pérez M, et al. Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid. Clin Transl Oncol. 2020;22(12):2364-2368. DOI: 10.1007/ s12094-020-02381-z.

 

Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763- 1770. DOI: 10.1016/S0140-6736(20)31189-2.

 

Sun H, Ning R, Tao Y, Yu C, Deng X, Zhao C, et al. Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study. J Am Geriatr Soc. 2020; 68(6):E19-E23. DOI: 10.1111/jgs.16533.

 

Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345-1355. DOI: 10.1001/jamainternmed.2020.3539.

 

Parra-Bracamonte GM, Lopez-Villalobos N, Parra-Bracamonte FE. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico. Ann Epidemiol. 2020;52:e93-e98. DOI: 10.1016/j. annepidem.2020.08.005.

 

Smith AA, Fridling J, Ibrahim D, Porter PS Jr. Identifying Patients at Greatest Risk of Mortality due to COVID-19: A New England Perspective. West J Emerg Med. 2020;21(4):785- 789. DOI: 10.5811/westjem.2020.6.47957.

 

Atkins JL, Masoli JAH, Delgado J, Pilling LC, Kuo CL, Kuchel GA, et al. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort. J Gerontol A Biol Sci Med Sci. 2020;75(11):2224-2230. DOI: 10.1093/gerona/glaa183.

 

Marhl M, Grubelnik V, Magdič M, Markovič R. Diabetes and metabolic syndrome as risk factors for COVID-19. Diabetes Metab Syndr. 2020;14(4):671-677. DOI: 10.1016/j. dsx.2020.05.013.

 

Xu L, Mao Y, Chen G. Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis. Aging (Albany NY). 2020;12(12):12410-12421. DOI: 10.18632/aging.103383.

 

Carrillo-Vega MF, Salinas-Escudero G, García-Peña C, Gutiérrez-Robledo LM, Parra-Rodríguez L. Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico. PLoS One. 2020;15(9):e0238905. DOI: 10.1371/journal.pone.0238905.

 

Cooper TJ, Woodward BL, Alom S, Harky A. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review. HIV Med. 2020;21(9):567-577. DOI: 10.1111/ hiv.12911.

 

Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2020;80:384-391. DOI: 10.1136/ annrheumdis-2020-218946.

 

Eldanasory OA, Rabaan AA, Al-Tawfiq JA. Can influenza vaccine modify COVID-19 clinical course? Travel Med Infect Dis. 2020;37:101872. DOI: 10.1016/j.tmaid.2020.101872.

 

Zhou MY, Xie XL, Peng YG, Wu MJ, Deng XZ, Wu Y, et al. From SARS to COVID-19: What we have learned about children infected with COVID-19. Int J Infect Dis. 2020;96:710- 714. DOI: 10.1016/j.ijid.2020.04.090.

 

Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147. DOI: 10.1371/journal. pone.0233147.

 


Enlaces refback

  • No hay ningún enlace refback.